Holen Sie sich die Stockscreener-App
4.24
0.95%
-0.0407
Handel nachbörslich:
4.24
Schlusskurs vom Vortag:
$4.2807
Offen:
$4.28
24-Stunden-Volumen:
29,443
Relative Volume:
0.09
Marktkapitalisierung:
$2.76M
Einnahmen:
$5.49M
Nettoeinkommen (Verlust:
$-6.35M
KGV:
-0.8015
EPS:
-5.29
Netto-Cashflow:
$-6.51M
1W Leistung:
-13.11%
1M Leistung:
-11.52%
6M Leistung:
-28.11%
1J Leistung:
-53.10%
1-Tages-Spanne:
$3.65
$4.29
1-Wochen-Bereich:
$3.65
$5.41
52-Wochen-Spanne:
$2.414
$15.70
Inmed Pharmaceuticals Inc Stock (INM) Company Profile
Firmenname
Inmed Pharmaceuticals Inc
Sektor
Branche
Telefon
(604) 669-7207
Adresse
1445-885 WEST GEORGIA ST., VANCOUVER
Vergleichen Sie INM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| INM | 4.24 | 2.76M | 5.49M | -6.35M | -6.51M | -5.29 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Inmed Pharmaceuticals Inc Aktie (INM) Neueste Nachrichten
InMed Pharmaceuticals (STU:MWG) Debt-to-EBITDA : -0.13 (As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) 3-Year Revenue Growth Rate : 0.00% (As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Profitability Rank : 1 (As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Growth Rank : 0 (As of Nov. 17, 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Issuance of Stock : €4.27 Mil (TTM As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Change In Working Capital : €-0.33 Mil (TTM As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Net Issuance of Debt : €0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Repurchase of Stock : €0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Inventory-to-Revenue : 0.95 (As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) PensionAndRetirementBenefit : €0.00 Mil (As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Cash Flow from Financing : €4.27 Mil (TTM As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Deferred Tax : €0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) 3-Year EBITDA Growth Rate : 70.10% (As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Retained Earnings : €-101.33 Mil (As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) ROE % Adjusted to Book Value : -14.96% (As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) 50-Day SMA : €4.49 (As of Nov. 16, 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) FCF Yield % : -226.50 (As of Nov. 16, 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) PE Ratio without NRI : At Loss (As of Nov. 16, 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Volatility : 115.20% (As of Nov. 16, 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Capex-to-Operating-Cash-Flo - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) 5-Year Dividend Growth Rate : 0.00% (As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Momentum Rank : 3 (As of Nov. 16, 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) 3-Year FCF Growth Rate : 71.00% (As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) EBITDA per Share : €-24.28 (TTM As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Gross Profit : €1.02 Mil (TTM As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Revenue per Share : €12.67 (TTM As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) 5-Day RSI : 43.89 (As of Nov. 16, 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Enterprise Value : €-2.41 Mil (As of Nov. 16, 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Forward Rate of Return (Yac - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Peter Lynch Fair Value : €-607.53 (As of Nov. 16, 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Effective Interest Rate on Debt % : 0.00% (As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Total Assets : €10.98 Mil (As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) 5-Year EBITDA Growth Rate : 55.00% (As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Days Payable : 57.29 (As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Debt-to-Equity : 0.11 (As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) 14-Day RSI : 47.30 (As of Nov. 16, 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Graham Number : €N/A (As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Total Inventories : €1.16 Mil (As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) GF Value Rank : 0 (As of Nov. 16, 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) 9-Day RSI : 45.74 (As of Nov. 16, 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) EV-to-Revenue : -0.57 (As of Nov. 16, 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) EBITDA : €-6.98 Mil (TTM As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) PE Ratio (TTM) : At Loss (As of Nov. 16, 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) EV-to-FCF : 0.37 (As of Nov. 16, 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Preferred Stock : €0.00 Mil (As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Free Cash Flow per Share : €-22.21 (TTM As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Dividends per Share : €0.00 (TTM As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Financial Strength : 5 (As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (STU:MWG) Shares Outstanding (EOP) : 8.92 Mil (As of Jun. 2024) - GuruFocus.com
InMed Pharmaceuticals (FRA:MWG) PE Ratio (TTM) : At Loss (As of Nov. 15, 2024) - GuruFocus.com
ARMISTICE CAPITAL, LLC Acquires New Holdings in InMed Pharmaceuticals Inc - GuruFocus.com
Finanzdaten der Inmed Pharmaceuticals Inc-Aktie (INM)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):